×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ILMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
08:33 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Stephens from $170.00 to $184.00. They now have an "overweight" rating on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Stephens from $170.00 to $184.00. They now have an "overweight" rating on the stock.
11/12
08:33 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $156.00 price target on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $156.00 price target on the stock.
11/12
12:17 am
ilmn
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics [Yahoo! Finance]
Low
Report
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics [Yahoo! Finance]
11/11
11:49 am
ilmn
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
11/11
08:09 am
ilmn
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Piper Sandler from $195.00 to $185.00. They now have an "overweight" rating on the stock.
Low
Report
Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Piper Sandler from $195.00 to $185.00. They now have an "overweight" rating on the stock.
11/11
04:22 am
ilmn
Whole Genome and Exome Sequencing Market Research 2024-2033: Driving Down Costs, Enhancing Patient Outcomes, and Influencing Global Healthcare Policies [Yahoo! Finance]
Low
Report
Whole Genome and Exome Sequencing Market Research 2024-2033: Driving Down Costs, Enhancing Patient Outcomes, and Influencing Global Healthcare Policies [Yahoo! Finance]
11/8
09:58 am
ilmn
Here's Why You Should Invest in Illumina (ILMN) [Yahoo! Finance]
Low
Report
Here's Why You Should Invest in Illumina (ILMN) [Yahoo! Finance]
11/7
11:18 am
ilmn
Minimal Residual Disease Testing Market Worth $4.45 billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]
Low
Report
Minimal Residual Disease Testing Market Worth $4.45 billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:00 pm
ilmn
Form SC 13G/A ILLUMINA, INC. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A ILLUMINA, INC. Filed by: VANGUARD GROUP INC
11/7
07:43 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Rollins Carissa
Medium
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Rollins Carissa
11/7
07:43 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Davies Scott M
Medium
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Davies Scott M
11/7
07:41 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Barnard Steven
Medium
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Barnard Steven
11/7
07:36 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Ericksen Scott D
Low
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Ericksen Scott D
11/7
07:34 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Leckman Patricia
Low
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Leckman Patricia
11/7
07:33 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Pegels Kevin Carl
Low
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Pegels Kevin Carl
11/6
06:01 am
ilmn
Form 10-Q ILLUMINA, INC. For: Sep 29
Medium
Report
Form 10-Q ILLUMINA, INC. For: Sep 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Illumina, Inc. (ILMN): Are Hedge Funds Right About This Stock? [Yahoo! Finance News]
9.2%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
TOP News Decliners
7/11
Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019
-15.3%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: